Journal cover Journal topic
Journal of Bone and Joint Infection An open-access journal of the European Bone and Joint Infection Society and the MusculoSkeletal Infection Society
Journal topic

Journal metrics

h5-index value: 15
h5-index15
Volume 4, issue 2
J. Bone Joint Infect., 4, 72–75, 2019
https://doi.org/10.7150/jbji.22118
© Author(s) 2019. This work is distributed under
the Creative Commons Attribution 4.0 License.
J. Bone Joint Infect., 4, 72–75, 2019
https://doi.org/10.7150/jbji.22118
© Author(s) 2019. This work is distributed under
the Creative Commons Attribution 4.0 License.

Brief report 02 Mar 2019

Brief report | 02 Mar 2019

Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study

C Joseph1, O Robineau2,3, M Titecat3,4, S Putman5, N Blondiaux6, C Loiez4, M Valette2, JL Schmit1, E Beltrand7, H Dézeque5, S Nguyen8, H Migaud3,5, and E Senneville2,3,5 C Joseph et al.
  • 1Infectious Diseases Department, University Hospital of Amiens, France
  • 2Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, France
  • 3Faculty of Medicine of Lille, Lille University 2
  • 4Laboratory of Microbiology, University Hospital of Lille, France
  • 5Orthopaedic Surgery Unit, University Hospital of Lille, France
  • 6Laboratory of Microbiology, Gustave Dron Hospital of Tourcoing, France
  • 7Orthopedic Surgery Unit, Gustave Dron Hospital, France
  • 8General Hospital of Béthune

Keywords: Daptomycin, Vancomycin, empirical antibiotic treatment, prosthetic joint infection

Abstract. Purpose: To compare safety and efficacy of Vancomycin (Van) versus Daptomycin (Dap) as post-operative empirical antibiotic treatment (PEAT) in patients with periprosthetic joint infections (PJIs).

Methods: Medical charts of patients treated empirically with Van or Dap in the post-operative period of total hip/knee prosthesis septic revision until the results of intra-operative culture were reviewed. Cefotaxime, cefepime or aztreonam were used in combination with Dap or Van.

Results: Twenty Dap patients were matched with 20 other Van patients according to the age and type of prosthesis. The ASA score and the distribution of the pathogens was similar in the two groups especially regarding the number of methicillin-resistant staphylococci. The mean duration of the PEAT was 6.07 ± 0.85 days. A total of 17 episodes of adverse events (AE) in 10 patients (25%) were recorded during the PEAT which led to discontinue the treatment in 5 patients, all of them treated with Van (P=0.02). At the end of a mean post-treatment follow-up of 618 +/- 219 days, 36 patients remained in remission of infection; 2 patients failed in each group.

Conclusions: Our observations suggest that PEAT with Van for septic revision of PJIs is associated with a higher discontinuation rate due to AE but with a similar outcome than it is with Dap.

Publications Copernicus
Download
Citation